IL5 and asthma: Firstly, these findings indicate that remodeling is present even in mild asthma, and it is driven to some degree by eosinophil-derived TGF-beta 1; secondly, anti-IL-5 can prevent this process by regulating the TGF-beta-enhanced deposition of matrix proteins through the reduction of eosinophils [60].